Immunex

Immunex was an American biotechnology company headquartered in Seattle, Washington, that was acquired by Amgen in 2002. The company was best known for developing Enbrel (etanercept), a biologic medicine for rheumatoid arthritis and other autoimmune diseases.

Source: https://www.amgen.com

etanerceptEnbrel

TNF blocker

Enbrel (etanercept) is a TNF blocker built as a decoy receptor fused to an antibody fragment. It mops up tumour necrosis factor before it can inflame joints and skin, and is used in rheumatoid arthritis, psoriatic disease, ankylosing spondylitis and plaque psoriasis.

In diseases such as rheumatoid arthritis and psoriasis, the immune system overproduces TNF, a chemical that keeps inflammation going. Etanercept is a

1 medicine explained